Search

everythinglearnresearchcommunity

for

Search:↓

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

AB+ blood group is more common in alopecia areata patients.

Dermoscopic and histopathological features combined can help diagnose Pityriasis versicolor.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

People with alopecia areata often have lower vitamin D levels than healthy people.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib is effective for severe alopecia areata but has some side effects.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.